A phase 1 study of oral LOXO 292 in adult patients with advanced solid tumors, including RET-fusion non-small cell lung cancer, medullary thyroid cancer and other tumors with increased RET activity Meeting Abstract
| Authors: | Drilon, A. E.; Bauer, T. M.; Subbiah, V.; Cabanillas, M.; Lahkani, N.; Wirth, L.; Oxnard, G.; Smith, S.; Eary, T.; Cruickshank, S.; Nguyen, M.; Rothenberg, S. |
| Abstract Title: | A phase 1 study of oral LOXO 292 in adult patients with advanced solid tumors, including RET-fusion non-small cell lung cancer, medullary thyroid cancer and other tumors with increased RET activity |
| Meeting Title: | 42nd ESMO Congress (ESMO 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2017 Sep 8-12 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-09-01 |
| Start Page: | mdx367.050 |
| Language: | English |
| ACCESSION: | WOS:000411324001075 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx367.050 |
| Notes: | Meeting Abstract: 417TiP -- Appears on page 138 of the abstract book -- Source: Wos |
